-
1
-
-
33845241195
-
The Trans-Atlantic Inter-Society Consensus (TASC II): document on management of peripheral arterial disease
-
Norgren L., Hiatt W.R., Dormandy J.A., et al. The Trans-Atlantic Inter-Society Consensus (TASC II): document on management of peripheral arterial disease. Eur J Vasc Endovasc Surg 2007, 33(Suppl 1):S1-S75.
-
(2007)
Eur J Vasc Endovasc Surg
, vol.33
, Issue.SUPPL 1
-
-
Norgren, L.1
Hiatt, W.R.2
Dormandy, J.A.3
-
3
-
-
70450189795
-
Inflammation in atherosclerosis: from pathophysiology to practice
-
Libby P., Ridker P.M., Hansson G.K., et al. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009, 54:2129-2138.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 2129-2138
-
-
Libby, P.1
Ridker, P.M.2
Hansson, G.K.3
-
4
-
-
42149099498
-
The molecular mechanisms of the thrombotic complications of atherosclerosis
-
Libby P. The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med 2008, 263:517-527.
-
(2008)
J Intern Med
, vol.263
, pp. 517-527
-
-
Libby, P.1
-
5
-
-
33748686575
-
Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use
-
Bender A.T., Beavo J.A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006, 58:488-520.
-
(2006)
Pharmacol Rev
, vol.58
, pp. 488-520
-
-
Bender, A.T.1
Beavo, J.A.2
-
6
-
-
79952525002
-
Shear-dependent suppression of platelet thrombus formation by phosphodiesterase 3 inhibition requires low levels of concomitant Gs-coupled receptor stimulation
-
Yoshida H., Okamura Y., Watanabe N., et al. Shear-dependent suppression of platelet thrombus formation by phosphodiesterase 3 inhibition requires low levels of concomitant Gs-coupled receptor stimulation. Thromb Haemost 2011, 105:487-495.
-
(2011)
Thromb Haemost
, vol.105
, pp. 487-495
-
-
Yoshida, H.1
Okamura, Y.2
Watanabe, N.3
-
7
-
-
0023944556
-
Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle
-
Tanaka T., Ishikawa T., Hagiwara M., et al. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology 1988, 36:313-320.
-
(1988)
Pharmacology
, vol.36
, pp. 313-320
-
-
Tanaka, T.1
Ishikawa, T.2
Hagiwara, M.3
-
8
-
-
34548558967
-
NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model
-
Ishiwata N., Noguchi K., Kawanishi M., et al. NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model. Life Sci 2007, 81:970-978.
-
(2007)
Life Sci
, vol.81
, pp. 970-978
-
-
Ishiwata, N.1
Noguchi, K.2
Kawanishi, M.3
-
9
-
-
0036839547
-
Collateral arteries grow from preexisting anastomoses in the rat hindlimb
-
Herzog S., Sager H., Khmelevski E., et al. Collateral arteries grow from preexisting anastomoses in the rat hindlimb. Am J Physiol Heart Circ Physiol 2002, 283:H2012-H2020.
-
(2002)
Am J Physiol Heart Circ Physiol
, vol.283
-
-
Herzog, S.1
Sager, H.2
Khmelevski, E.3
-
10
-
-
0025940175
-
Implications of thrombosis and vasospasm in peripheral vascular disease
-
Hollenberg N.K. Implications of thrombosis and vasospasm in peripheral vascular disease. J Cardiovasc Pharmacol 1991, 17(Suppl 5):S21-S28.
-
(1991)
J Cardiovasc Pharmacol
, vol.17
, Issue.SUPPL 5
-
-
Hollenberg, N.K.1
-
11
-
-
0021876264
-
The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man
-
Akiyama H., Kudo S., Shimizu T. The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man. Arzneimittelforschung 1985, 35:1133-1140.
-
(1985)
Arzneimittelforschung
, vol.35
, pp. 1133-1140
-
-
Akiyama, H.1
Kudo, S.2
Shimizu, T.3
-
12
-
-
0035370855
-
Exercise-induced hyperemia unmasks regional blood flow deficit in experimental hindlimb ischemia
-
Brevetti L.S., Paek R., Brady S.E., et al. Exercise-induced hyperemia unmasks regional blood flow deficit in experimental hindlimb ischemia. J Surg Res 2001, 98:21-26.
-
(2001)
J Surg Res
, vol.98
, pp. 21-26
-
-
Brevetti, L.S.1
Paek, R.2
Brady, S.E.3
-
13
-
-
0018903907
-
Protective effect of ticlopidine on experimentally induced peripheral arterial occlusive disease in rats
-
Ashida S., Ishihara M., Ogawa H., et al. Protective effect of ticlopidine on experimentally induced peripheral arterial occlusive disease in rats. Thromb Res 1980, 18:55-67.
-
(1980)
Thromb Res
, vol.18
, pp. 55-67
-
-
Ashida, S.1
Ishihara, M.2
Ogawa, H.3
-
14
-
-
33645818728
-
Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats
-
Uemura T., Takamatsu H., Kawasaki T., et al. Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats. Eur J Pharmacol 2006, 536:154-161.
-
(2006)
Eur J Pharmacol
, vol.536
, pp. 154-161
-
-
Uemura, T.1
Takamatsu, H.2
Kawasaki, T.3
-
15
-
-
0029128480
-
Differential vasodilatory action of 2-octynyladenosine (YT-146), an adenosine A2 receptor agonist, in the isolated rat femoral artery and vein
-
Abiru T., Endo K., Machida H. Differential vasodilatory action of 2-octynyladenosine (YT-146), an adenosine A2 receptor agonist, in the isolated rat femoral artery and vein. Eur J Pharmacol 1995, 281:9-15.
-
(1995)
Eur J Pharmacol
, vol.281
, pp. 9-15
-
-
Abiru, T.1
Endo, K.2
Machida, H.3
-
16
-
-
40149099168
-
Endothelial alpha1-adrenoceptors regulate neo-angiogenesis
-
Ciccarelli M., Santulli G., Campanile A., et al. Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. Br J Pharmacol 2008, 153:936-946.
-
(2008)
Br J Pharmacol
, vol.153
, pp. 936-946
-
-
Ciccarelli, M.1
Santulli, G.2
Campanile, A.3
-
17
-
-
33644693118
-
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system
-
Iaccarino G., Ciccarelli M., Sorriento D., et al. Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 2005, 97:1182-1189.
-
(2005)
Circ Res
, vol.97
, pp. 1182-1189
-
-
Iaccarino, G.1
Ciccarelli, M.2
Sorriento, D.3
-
18
-
-
85047693822
-
Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles
-
Lee E.W., Michalkiewicz M., Kitlinska J., et al. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 2003, 111:1853-1862.
-
(2003)
J Clin Invest
, vol.111
, pp. 1853-1862
-
-
Lee, E.W.1
Michalkiewicz, M.2
Kitlinska, J.3
-
19
-
-
0028198615
-
Modulation of cellular responses by hormones: role of cAMP specific, rolipram-sensitive phosphodiesterases
-
Sette C., Vicini E., Conti M. Modulation of cellular responses by hormones: role of cAMP specific, rolipram-sensitive phosphodiesterases. Mol Cell Endocrinol 1994, 100:75-79.
-
(1994)
Mol Cell Endocrinol
, vol.100
, pp. 75-79
-
-
Sette, C.1
Vicini, E.2
Conti, M.3
-
20
-
-
78049244831
-
Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo
-
Nakaya K., Ayaori M., Uto-Kondo H., et al. Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo. Atherosclerosis 2010, 213:135-141.
-
(2010)
Atherosclerosis
, vol.213
, pp. 135-141
-
-
Nakaya, K.1
Ayaori, M.2
Uto-Kondo, H.3
-
21
-
-
67349112126
-
Cilostazol inhibits modified low-density lipoprotein uptake and foam cell formation in mouse peritoneal macrophages
-
Okutsu R., Yoshikawa T., Nagasawa M., et al. Cilostazol inhibits modified low-density lipoprotein uptake and foam cell formation in mouse peritoneal macrophages. Atherosclerosis 2009, 204:405-411.
-
(2009)
Atherosclerosis
, vol.204
, pp. 405-411
-
-
Okutsu, R.1
Yoshikawa, T.2
Nagasawa, M.3
-
22
-
-
56649095559
-
Cilostazol increases 3T3-L1 preadipocyte differentiation with improved glucose uptake associated with activation of peroxisome proliferator-activated receptor-gamma transcription
-
Park S.Y., Lee J.H., Kim K.Y., et al. Cilostazol increases 3T3-L1 preadipocyte differentiation with improved glucose uptake associated with activation of peroxisome proliferator-activated receptor-gamma transcription. Atherosclerosis 2008, 201:258-265.
-
(2008)
Atherosclerosis
, vol.201
, pp. 258-265
-
-
Park, S.Y.1
Lee, J.H.2
Kim, K.Y.3
-
23
-
-
33750369864
-
Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism
-
Hashimoto A., Miyakoda G., Hirose Y., et al. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis 2006, 189:350-357.
-
(2006)
Atherosclerosis
, vol.189
, pp. 350-357
-
-
Hashimoto, A.1
Miyakoda, G.2
Hirose, Y.3
-
24
-
-
0033503548
-
Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease
-
Bramer S.L., Forbes W.P., Mallikaarjun S. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease. Clin Pharmacokinet 1999, 37(Suppl 2):1-11.
-
(1999)
Clin Pharmacokinet
, vol.37
, Issue.SUPPL 2
, pp. 1-11
-
-
Bramer, S.L.1
Forbes, W.P.2
Mallikaarjun, S.3
|